|
Insights: The Corporate and Securities Law Advisor by Amy L. Goodman, Esq. |
|
Media:Price Per Unit:
$586
Call for Pricing |
PIN:SS08943524 Format:Paperback Pub. Cycle:12 Issues per year More Info: 888-224-7377 |
|
For more than two decades, Insights: The Corporate & Securities Law Advisor has provided a direct pipeline to the latest developments in corporate and securities law on the state, national and international levels. Each month, this timely and informative journal scours the globe to report on critical developments in the field and analyze their implications to your practice. With Amy Goodman—one of the nation's most widely known and respected securities law attorneys and a former SEC insider—as the Editor-in-Chief, and insights from seasoned securities lawyers at top firms and in-house legal departments, Insights is the best way to stay current with what's happening and what's important in the dynamic securities law environment.
Insights covers substantive law developments in corporate and securities law on the state, national, and international levels. Transactions, office practice, court decisions, and behind-the-scenes SEC and regulatory developments are all analyzed and interpreted by the nation's most respected corporate lawyers in firms, corporations, government, and academia. Each month vital topics are covered, such as the effective use of fight letters in proxy contests, SEC losses in recent insider trading cases, disclosure obligations of issues of municipal securities, ethical duties for lawyers under the Sarbanes-Oxley Act, and the corporate opportunity doctrine as it relates to IPO's. Plus, regular departments in each issue include:
SEC Deputy Director Shelley Parratt urged companies not to wait for staff comments to improve their compensation discussion and analysis ("CD&A"). After three years of comments on how to improve their disclosure, Parratt said companies now should be prepared to amend their filings if they do not materially comply with the rules.
Insights into legislative activity, cases of note, and other breaking news.
Insights and commentary on health reform.
A forum to discuss antitrust and trade regulation law.
Commentary and musings about securities regulation.